Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Lymphoid-primed multipotent progenitors with down-regulated megakaryocyte-erythroid (MkE) potential are restricted to cells with high levels of cell-surface FLT3 expression, whereas HSCs and MkE progenitors lack detectable cell-surface FLT3. These findings are compatible with FLT3 cell-surface expression not being detectable in the fully multipotent stem/progenitor cell compartment in mice. If so, this process could be distinct from human hematopoiesis, in which FLT3 already is expressed in multipotent stem/progenitor cells. The expression pattern of Flt3 (mRNA) and FLT3 (protein) in multipotent progenitors is of considerable relevance for mouse models in which prognostically important Flt3 mutations are expressed under control of the endogenous mouse Flt3 promoter. Herein, we demonstrate that mouse Flt3 expression initiates in fully multipotent progenitors because in addition to lymphoid and granulocyte-monocyte progenitors, FLT3(-) Mk- and E-restricted downstream progenitors are also highly labeled when Flt3-Cre fate mapping is applied.

Original publication




Journal article



Publication Date





1544 - 1548


Haematopoietic Stem Cell Laboratory, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.


Monocytes, Bone Marrow Cells, Granulocyte Precursor Cells, Hematopoietic Stem Cells, Cell Membrane, Multipotent Stem Cells, Animals, Mice, Inbred C57BL, Mice, Transgenic, Humans, Mice, Luminescent Proteins, Bone Marrow Transplantation, Flow Cytometry, Gene Expression Profiling, Reverse Transcriptase Polymerase Chain Reaction, Cell Lineage, fms-Like Tyrosine Kinase 3, Erythroid Precursor Cells, Megakaryocyte Progenitor Cells